PREDICTION OF ADVERSE EFFECTS OF AMIODARONE BY SIGNAL AVERAGING IN HCM PATIENTS
PREDICTION OF ADVERSE EFFECTS OF AMIODARONE BY SIGNAL AVERAGING IN HCM PATIENTS
批准号:
3920190
负责人:
L FANANAPAZIR
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Analysis of the terminal portion of the QRS of the ECG and
detection of late potential (LP) by signal averaging (SAE) is a
noninvasive method for identifying patients who are prone to
develop ventricular tachycardia (VT) and are therefore at risk for
sudden cardiac death. We have earlier shown that there was a and
correlation between the presence of LP and inducibility of VT in
patients with hypertrophic cardiomyopathy (HCM). Amiodarone is a
patient antiarrhythmic drug. The purpose of the present
investigation was to determine whether changes in SAE predicted
efficacy and proarrhythmic potential in 14 HCM patients treated
with amiodarone. Amiodarone increased the incidence of LP. This
was associated with the greater ease with which VT was induced
during programmed electrical stimulation. Thus SAE may identify
HCM patients in whom amiodarone is proarrhythmic and may be at
increased risk for sudden cardiac death.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INDUCTION OF MALIGNANT VENTRICULAR TACHYCARDIA ON AMIODARONE IN HCM PATIENTS
-
批准号:3920192
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
CENTRAL CORE DISEASE IN HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3843406
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
INHERITED CARDIAC DISEASES--HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3757734
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
MANAGEMENT OF SYMPTOMS AND ARRHYTHMIAS IN HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3858130
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
MANAGEMENT OF MALIGNANT VENTRICULAR ARRHYTHMIA IN PATIENTS WITH IHSS
-
批准号:3916506
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
ABNORMAL MYOSIN IN-VITRO MOTILITY ACTIVITY IN HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3843405
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
PROGNOSTIC DETERMINANTS IN HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3843411
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
PROGRAMMED STIMULATION FINDINGS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3920187
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
MANAGEMENT OF MALIGNANT VENTRICULAR ARRHYTHMIA IN PATIENTS WITH IHSS
-
批准号:3837966
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
SKELETAL MYOFIBER TENSION IN HYPERTROPHIC CARDIOLOGY
-
批准号:3843407
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
CORRELATION OF SIGNAL AVERAGING WITH PROGRAMMED STIMULATION IN HCM PATIENTS
-
批准号:3920188
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
ARRHYTHMIAS IN HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3879051
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
MANAGEMENT OF MALIGNANT VENTRICULAR ARRHYTHMIA IN PATIENTS WITH IHSS
-
批准号:3874325
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
PROGNOSIS AND ELECTROPHYSIOLOGIC FUNDINGS IN HCM SUDDEN CARDIAC DEATH SURVIVORS
-
批准号:3920191
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
DUAL CHAMBER PACING FOR LV OUTFLOW OBSTRUCTION IN HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3843408
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
A-V NODE ABLATION IN HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3843409
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
GENOTYPE/PHENOTYPE STUDIES IN HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3843410
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3779621
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位: